Answers are grounded in this paper and cite their sources.
A 45-year-old female, with no significant past medical history, presented with high serum prolactin (151 ng/mL, reference interval 3-27 ng/mL). Oral bromocriptine (2.5 mg/d) was prescribed. Later (Fig. 1), she noted a breast lump, which progressively increased in size, became painful, was accompanied by redness and swelling, and had a milky white nipple discharge. The lump was excised; pathology revealed plasma cell mastitis. Six months later, she noted a second lump, which was excised and also revealed plasma cell mastitis. ... ... The answers are on the next page. Plasma cell mastitis and other inflammatory breast conditions are associated with increased prolactin concentrations (1). This can be transient and due to stimulation of surrounding tissue (neurogenic hyperprolactinemia) or persistent, most often due to a tumor. Bromocriptine is a dopamine agonist that blocks prolactin secretion by the anterior pituitary. Serum prolactin should be measured after symptoms resolve to investigate abnormal hypothalamic--pituitary function when concentrations do not return to normal.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: